IP Library Granted Patent US 11,045,307
Granted Patent B2
US 11,045,307 · App. 16/300,189 · Granted Jun 29, 2021

Medical implants and methods of preparation thereof

Inventors: Juan José Chacón Quirós (Alajuela, CR); Roberto De Mezerville (Alajuela, CR); John Hancock (Santa Barbara, CA); Salvador Dada (Alajuela, CR); Nathalia Araujo (Alajuela, CR); Josue Cascante (Alajuela, CR); Rudy A. Mazzocchi (New York, NY)
Assignee: Establishment Labs S.A.
A61F2/12A61L27/18A61L27/50B29C33/3842B29C33/424A61F2/30942A61F2210/0014A61F2220/0008A61F2240/001A61F2250/0025A61F2250/0085A61F2250/0098B29L2031/7532
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,045,307
App. No.
16/300,189
Granted
Jun 29, 2021
Kind
B2
Abstract

Medical implants comprising biocompatible materials and having surface features that may assist in biocompatibility upon implantation in the body are described. Methods for manufacturing such implants are also described. The manufacturing process may include applying a biocompatible material to a texturized surface of a mold. The implants may include various features to assist their positioning, fixation, and/or identification during and/or after implantation.

Claims (24)

1. A breast implant, comprising:

a shell comprising a biocompatible material and having an outer surface configured to contact tissue and an inner surface facing a cavity defined by the shell;

wherein the outer surface of the shell includes a plurality of peaks distributed at a density ranging from about 20,000 peaks/cm 2 to about 65,000 peaks/cm 2 , the outer surface having an average roughness ranging from about 3.0 μm to about 5.0 μm and a kurtosis value ranging from about 3.0 to about 7.0; and

wherein the inner surface of the shell has an average roughness that is higher than the average roughness of the outer surface of the shell.

2. The breast implant of claim 1 , further comprising a liquid or a gel inside the cavity.

3. The breast implant of claim 1 , wherein the biocompatible material comprises silicone, and a total thickness of the shell ranges from about 0.1 mm to about 1.2 mm.

4. The breast implant of claim 1 , wherein the average roughness of the outer surface of the shell ranges from about 4.0 μm to about 4.5 μm.

5. The breast implant of claim 1 , wherein the outer surface of the shell has a skewness value ranging from about −0.2 to about 2.0.

6. The breast implant of claim 1 , wherein the outer surface of the shell has a skewness value ranging from 0 to about 1.0.

7. The breast implant of claim 1 , wherein the plurality of peaks of the outer surface of the shell have a maximum peak height ranging from about 10 μm to about 20 μm, and a maximum valley depth ranging from about 8 μm to about 18 μm.

8. The breast implant of claim 1 , wherein the plurality of peaks of the outer surface are distributed at a density ranging from about 40,000 peaks/cm 2 to about 50,000 peaks/cm 2 .

9. The breast implant of claim 1 , wherein the outer surface of the shell includes a posterior side and an anterior side, the posterior side being closer to a chest cavity of a patient upon implantation, and wherein an entirety of the anterior side has a kurtosis value ranging from about 3.0 to about 5.0.

10. The breast implant of claim 9 , wherein the posterior side of the outer surface of the shell includes a patch.

11. A breast implant, comprising:

a shell comprising a biocompatible material and including an inner surface and an outer surface, the outer surface having an average roughness ranging from about 2.0 μm to about 6.0 μm, and the inner surface having an average roughness that is higher than the average roughness of the outer surface; and

a filling in contact with the inner surface of the shell.

12. The breast implant of claim 11 , wherein the filling comprises a silicone gel.

13. The breast implant of claim 12 , wherein the breast implant is configured to withstand elongation and compression forces during minimally-invasive surgery without separation of the silicone gel from the inner surface of the shell.

14. The breast implant of claim 11 , wherein the biocompatible material comprises silicone, and the shell has an elongation value ranging from about 650% to about 750%.

15. The breast implant of claim 11 , wherein the shell comprises at least one colored barrier layer that prevents or inhibits passage of the filling through the shell.

16. The breast implant of claim 11 , wherein the outer surface of the shell has a positive skewness value.

17. The breast implant of claim 11 , wherein the outer surface of the shell has a skewness value ranging from 0.2 to about 1.0 and includes a plurality of peaks distributed at a density ranging from about 40,000 peaks/cm′ to about 50,000 peaks/cm 2 .

18. The breast implant of claim 11 , wherein at least one of the shell or the filling comprises a radiopaque material.

19. The breast implant of claim 18 , wherein the filling comprises a liquid or a gel that comprises a radiopaque salt.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE SPELLING OF INVENTOR HANCOCK'S FIRST NAME PREVIOUSLY RECORDED AT REEL: 061825 FRAME: 0352. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded May 8, 2023
From: CHACON QUIROS, JUAN JOSE; DE MEZERVILLE, ROBERTO; HANCOCK, JOHN; DADA, SALVADOR; ARAUJO, NATHALIA; CASCANTE, JOSUE; MAZZOCCHI, RUDY A
To: ESTABLISHMENT LABS S.A.
Reel/Frame 063572/0574 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2022
From: QUIROS, JUAN JOSE CHACON; DE MEZERVILLE, ROBERTO; HANCOCK, JOHNATHAN; DADA, SALVADOR; ARAUJO, NATHALIA; CASCANTE, JOSUE; MAZZOCCHI, RUDY A
To: ESTABLISHMENT LABS S.A.
Reel/Frame 061825/0352 →
SECURITY INTEREST Recorded Apr 29, 2022
From: ESTABLISHMENT LABS SOCIEDAD ANONIMA; JAMM TECHNOLOGIES, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 059823/0935 →
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2022
From: MADRYN HEALTH PARTNERS, LP
To: ESTABLISHMENT LABS SOCIEDAD ANONIMA
Reel/Frame 059735/0233 →
SECURITY INTEREST Recorded Jul 18, 2019
From: ESTABLISHMENT LABS SOCIEDAD ANONIMA
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 049790/0308 →
Continuity (3)
Provisional Application 62410121 · Oct 19, 2016
Provisional Application 62334667 · May 11, 2016
Related Publication 20190142574A1 · May 16, 2019
Cited By (1)
US 12,569,331